Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> <b>NAMS 2014.</b> Guideline & mobile app for menopausal sx mgmnt & hormonal/nonhormonal therapy decision making from NAMS. <i>Menopause: The Journal of The North American Menopause Society.</i> Vol. 22, No. 3, pp. 000/000. <a href=http://www.menopause.org/docs/default-source/2014/menopro-app-algorithm-2014.pdf><b><u>PDF</u></b></a><br><br>
Women at high risk of osteoporotic fracture but unable to tolerate standard preventive medications also may be reasonable candidates for systemic HT, even if they do not have mod-to-severe vasomotor sx. HT for osteoporosis prevention is controversial.
<br><br>
<sup>2</sup> <b>NAMS 2020.</b> The 2020 Genitourinary Syndrome of Menopause Position Statement of the North American Menopause Society. <i>Menopause: The Journal of the North American Menopause Society.</i> Vol. 27, No. 9, pp. 976/992. <a href=https://www.menopause.org/docs/default-source/default-document-library/2020-gsm-ps.pdf><b><u>PDF</u></b></a>
Women at high risk of osteoporotic fracture but unable to tolerate standard preventive medications also may be reasonable candidates for systemic HT, even if they do not have mod-to-severe vasomotor sx. HT for osteoporosis prevention is controversial.
<br><br>
<sup>2</sup> <b>NAMS 2020.</b> The 2020 Genitourinary Syndrome of Menopause Position Statement of the North American Menopause Society. <i>Menopause: The Journal of the North American Menopause Society.</i> Vol. 27, No. 9, pp. 976/992. <a href=https://www.menopause.org/docs/default-source/default-document-library/2020-gsm-ps.pdf><b><u>PDF</u></b></a>
Detail Type
Text
Detail Text
Patient Type Detail Header (Long)
Avoid HT<sup>1</sup>